Loading...
XNAS
RXST
Market cap291mUSD
Aug 28, Last price  
7.05USD
Name

Rxsight Inc

Chart & performance

D1W1MN
XNAS:RXST chart
P/E
P/S
2.17
EPS
Div yield, %
Shrs. gr., 5y
16.64%
Rev. gr., 5y
55.74%
Revenues
Net income
CFO

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

As a medical technology enterprise, RxSight, Inc. (which operated as Calhoun Vision, Inc. until its rebranding in February 2017) specializes in the innovation, manufacturing, and distribution of light-adjustable intraocular lenses (LALs). These advanced lenses are specifically designed for use in cataract surgery, serving patients in both domestic and international markets. The cornerstone of the company's offerings is the RxSight system, a sophisticated solution that enables ophthalmologists to precisely tailor and enhance a patient's visual acuity following cataract removal. An integral part of this system is the RxSight light delivery device, an in-office instrument. This device emits UV light in a carefully controlled pattern to modify the LAL, thereby ensuring optimal visual correction after the surgical procedure. RxSight's primary clientele consists of eye surgeons specializing in cataract treatments. The company was founded in 1997 and its corporate headquarters are situated in Aliso Viejo, California.
IPO date
Jul 30, 2021
Employees
292
Domiciled in
US
Incorporated in
US

Valuation

No data to show